GSK Announces Director/PDMR Shareholding
Why we think this is neutral
This RNS announcement is related to director/PDMR shareholding changes, which is not one of the mandatory news types that would require a more detailed analysis. As such, the sentiment is considered neutral.
Key Points
- Director David Redfern acquired 25 ordinary shares at £12.73 per share
- Company Secretary Victoria Whyte acquired 22 ordinary shares at £12.73 per share
Summary
The healthcare company has announced changes to director and PDMR shareholdings.
GSK plc has announced changes to the shareholdings of two of its directors, David Redfern and Victoria Whyte. The changes are related to the re-investment of dividends paid to shareholders on 10 April 2025, on ordinary shares held within an ISA.
DIRECTOR DEALINGS